Clinical Trials Search Results

Page 1 of 1 | Results 1 - 8 of 8

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Lung Cancer
Amaryllis Gil, MD

Elmhurst Memorial Hospital

Accepting Participants

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Lung Cancer
Amaryllis Gil, MD

Elmhurst Memorial Hospital

Accepting Participants

Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer (NSCLC)

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery

Lung Cancer
Maria Quejada, MD

Naperville, Plainfield

Accepting Participants

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery

Lung Cancer
Amaryllis Gil, MD

Elmhurst Memorial Hospital

Accepting Participants
Page 1 of 1 | Results 1 - 8 of 8